2-232535148-C-T
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_StrongPP5
The NM_000751.3(CHRND):c.1390C>T(p.Arg464*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
 Genomes: 𝑓 0.000020   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.0000034   (  0   hom.  ) 
Consequence
 CHRND
NM_000751.3 stop_gained
NM_000751.3 stop_gained
Scores
 3
 2
 2
Clinical Significance
Conservation
 PhyloP100:  0.331  
Publications
2 publications found 
Genes affected
 CHRND  (HGNC:1965):  (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015] 
CHRND Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 3AInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - congenital myasthenic syndrome 3BInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
 - congenital myasthenic syndrome 3CInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
 - postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of  0.106 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PP5
Variant 2-232535148-C-T is Pathogenic according to our data. Variant chr2-232535148-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 18370.Status of the report is no_assertion_criteria_provided, 0 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CHRND | NM_000751.3  | c.1390C>T | p.Arg464* | stop_gained | Exon 12 of 12 | ENST00000258385.8 | NP_000742.1 | |
| CHRND | NM_001256657.2  | c.1345C>T | p.Arg449* | stop_gained | Exon 11 of 11 | NP_001243586.1 | ||
| CHRND | NM_001311196.2  | c.1087C>T | p.Arg363* | stop_gained | Exon 12 of 12 | NP_001298125.1 | ||
| CHRND | NM_001311195.2  | c.808C>T | p.Arg270* | stop_gained | Exon 10 of 10 | NP_001298124.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152210Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3
AN: 
152210
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.00000342  AC: 5AN: 1461832Hom.:  0  Cov.: 32 AF XY:  0.00000550  AC XY: 4AN XY: 727228 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
5
AN: 
1461832
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
4
AN XY: 
727228
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33478
American (AMR) 
 AF: 
AC: 
0
AN: 
44718
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53388
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5756
European-Non Finnish (NFE) 
 AF: 
AC: 
3
AN: 
1112008
Other (OTH) 
 AF: 
AC: 
1
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152210Hom.:  0  Cov.: 33 AF XY:  0.0000134  AC XY: 1AN XY: 74366 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3
AN: 
152210
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
1
AN XY: 
74366
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
41464
American (AMR) 
 AF: 
AC: 
0
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5196
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68020
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.575 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ESP6500AA 
 AF: 
AC: 
0
ESP6500EA 
 AF: 
AC: 
1
ClinVar
Significance: Pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Lethal multiple pterygium syndrome    Pathogenic:1 
Feb 01, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Benign 
N 
 PhyloP100 
 Vest4 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.